Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from

Susanne Schmidt1, Dan Mellström, Ensio Norjavaara

  • 1Department of Pediatrics, Borås Central Hospital, Borås, Sweden. schm-sus@online.no

Insights

Low bone mineral density (BMD) is common in Swedish pediatric patients with inflammatory bowel disease (IBD). Male gender, low body mass index (BMI), and azathioprine treatment are linked to decreased BMD in these children.

Area of Science:

  • Pediatric Endocrinology
  • Gastroenterology
  • Bone Metabolism

Background:

  • Low bone mineral density (BMD) is a recognized complication in pediatric inflammatory bowel disease (IBD).
  • Understanding BMD status and contributing factors in this population is crucial for early intervention.

Purpose of the Study:

  • To assess BMD in Swedish children and adolescents diagnosed with IBD.
  • To identify potential factors influencing BMD levels in pediatric IBD patients.

Main Methods:

  • A cohort of 144 pediatric IBD patients underwent dual-energy X-ray absorptiometry (DXA) for whole body and spine BMD assessment.
  • BMD values were standardized as Z-scores using pediatric reference data.

Main Results:

  • Pediatric IBD patients exhibited significantly lower lumbar spine BMD Z-scores compared to healthy controls.
  • Nearly half of the patients with Crohn's disease (CD) and ulcerative colitis (UC) presented with decreased BMD (Z-score < -1 SD).
  • Male gender, low body mass index (BMI), and azathioprine treatment were independently associated with lower lumbar spine BMD.

Conclusions:

  • Low BMD is prevalent among Swedish pediatric IBD patients.
  • Male sex, low BMI, and azathioprine use are identified as risk factors for reduced BMD.
  • Azathioprine may serve as an indicator of disease severity impacting bone health.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...